BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31269481)

  • 1. Association of Urinary Plasminogen-Plasmin with Edema and Epithelial Sodium Channel Activation in Patients with Nephrotic Syndrome.
    Chen JL; Wang L; Yao XM; Zang YJ; Wang Y; Li ZJ; Pearce D; Wang H
    Am J Nephrol; 2019; 50(2):92-104. PubMed ID: 31269481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC.
    Andersen RF; Buhl KB; Jensen BL; Svenningsen P; Friis UG; Jespersen B; Rittig S
    Pediatr Nephrol; 2013 Aug; 28(8):1227-34. PubMed ID: 23503750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasminuria with Overhydration in Patients with CKD.
    Schork A; Woern M; Kalbacher H; Voelter W; Nacken R; Bertog M; Haerteis S; Korbmacher C; Heyne N; Peter A; Häring HU; Artunc F
    Clin J Am Soc Nephrol; 2016 May; 11(5):761-769. PubMed ID: 26933188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
    Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
    Bohnert BN; Daiminger S; Wörn M; Sure F; Staudner T; Ilyaskin AV; Batbouta F; Janessa A; Schneider JC; Essigke D; Kanse S; Haerteis S; Korbmacher C; Artunc F
    Acta Physiol (Oxf); 2019 Dec; 227(4):e13286. PubMed ID: 31006168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of renal NaCl retention in proteinuric disease.
    Svenningsen P; Friis UG; Versland JB; Buhl KB; Møller Frederiksen B; Andersen H; Zachar RM; Bistrup C; Skøtt O; Jørgensen JS; Andersen RF; Jensen BL
    Acta Physiol (Oxf); 2013 Mar; 207(3):536-45. PubMed ID: 23216619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmin in nephrotic urine activates the epithelial sodium channel.
    Svenningsen P; Bistrup C; Friis UG; Bertog M; Haerteis S; Krueger B; Stubbe J; Jensen ON; Thiesson HC; Uhrenholt TR; Jespersen B; Jensen BL; Korbmacher C; Skøtt O
    J Am Soc Nephrol; 2009 Feb; 20(2):299-310. PubMed ID: 19073825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro.
    Buhl KB; Oxlund CS; Friis UG; Svenningsen P; Bistrup C; Jacobsen IA; Jensen BL
    J Hypertens; 2014 Aug; 32(8):1672-7; discussion 1677. PubMed ID: 24805959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary plasmin activates collecting duct ENaC current in preeclampsia.
    Buhl KB; Friis UG; Svenningsen P; Gulaveerasingam A; Ovesen P; Frederiksen-Møller B; Jespersen B; Bistrup C; Jensen BL
    Hypertension;